Search by Drug Name or NDC
NDC 55150-0267-05 FLUPHENAZINE DECANOATE 125 mg/5mL Details
FLUPHENAZINE DECANOATE 125 mg/5mL
FLUPHENAZINE DECANOATE is a INTRAMUSCULAR; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is FLUPHENAZINE DECANOATE.
Product Information
| NDC | 55150-0267 |
|---|---|
| Product ID | 55150-267_5252b3d9-df12-4b15-b4b3-7aa52cbc1d9c |
| Associated GPIs | 59200025302005 |
| GCN Sequence Number | 003818 |
| GCN Sequence Number Description | fluphenazine decanoate VIAL 25 MG/ML INJECTION |
| HIC3 | H2G |
| HIC3 Description | ANTIPSYCHOTICS,PHENOTHIAZINES |
| GCN | 14540 |
| HICL Sequence Number | 001624 |
| HICL Sequence Number Description | FLUPHENAZINE DECANOATE |
| Brand/Generic | Generic |
| Proprietary Name | FLUPHENAZINE DECANOATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | FLUPHENAZINE DECANOATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; SUBCUTANEOUS |
| Active Ingredient Strength | 125 |
| Active Ingredient Units | mg/5mL |
| Substance Name | FLUPHENAZINE DECANOATE |
| Labeler Name | Eugia US LLC |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207739 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0267-05 (55150026705)
| NDC Package Code | 55150-267-05 |
|---|---|
| Billing NDC | 55150026705 |
| Package | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-267-05) / 5 mL in 1 VIAL, MULTI-DOSE |
| Marketing Start Date | 2017-10-17 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 16.2184 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | FLUPHENAZINE DEC 125 MG/5 ML |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis